Alpha Financial Advisors LLC Invests $798,000 in UnitedHealth Group Incorporated $UNH

Alpha Financial Advisors LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,559 shares of the healthcare conglomerate’s stock, valued at approximately $798,000. UnitedHealth Group accounts for about 0.3% of Alpha Financial Advisors LLC’s investment portfolio, making the stock its 22nd biggest holding.

Several other large investors have also made changes to their positions in UNH. Bayforest Capital Ltd lifted its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 50 shares in the last quarter. Glass Jacobson Investment Advisors llc increased its stake in UnitedHealth Group by 80.9% during the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 55 shares in the last quarter. Kentucky Trust Co lifted its position in shares of UnitedHealth Group by 53.8% in the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after acquiring an additional 50 shares in the last quarter. Finally, Nova Wealth Management Inc. increased its position in shares of UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after purchasing an additional 78 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Morgan Stanley raised their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Robert W. Baird reissued an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a report on Wednesday, October 29th. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Stock Up 0.8%

Shares of UNH opened at $324.29 on Friday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm has a market cap of $293.75 billion, a P/E ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company’s 50-day moving average price is $345.84 and its 200 day moving average price is $322.64. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter last year, the company posted $7.15 EPS. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.